This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board to approve September 2026 unaudited results
CHEMFAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chemfab Alkalis will hold a Board meeting on 28 October 2026 at 11:30 AM to approve unaudited standalone and consolidated results for the quarter and half-year ended 30 September 2026. The trading window for directors, designated employees, insiders and relatives remains closed until 48 hours after results are declared, currently through 30 October 2026.
The announcement gives the results date but provides no financial figures or performance outlook; market reaction will depend on the declared results.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹75.61 Cr | ₹76.56 Cr | −1.2% |
| Operating profit | −₹3.32 Cr | −₹3.09 Cr | loss widened |
| Profit after tax | −₹2.11 Cr | −₹2.01 Cr | loss widened |
| EBITDA margin | 9.3% | 7.1% | +2.2 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.